A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

October 31, 2021

Primary Completion Date

April 30, 2023

Study Completion Date

July 31, 2024

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

thrombomodulin alfa

Weight based dose of reconstituted treatment administered through intravenous drip infusion on Day1 of each chemotherapy cycle

DRUG

Placebo

Weight based dose of reconstituted treatment administered through intravenous drip infusion on Day1 of each chemotherapy cycle